PAQR9 and cholangiocarcinoma: Anatomical tumor recurrence between the lungs, liver, lymph nodes, bones, and brain revealed significant differential expression for CCM1, PAQR9, and PGRMC1, along with AFP, in HCC patients (Figure 3H), while no significance was observed for CCA patients (Supplementary Figure S4B).